Schedule 13G ownership disclosure

AVEO PHARMACEUTICALS INC

Security class unavailable · CUSIP: 053588307

Event date: 2022-10-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-22-029201
Form type
SC 13G/A
Filer
AVEO PHARMACEUTICALS, INC.
CIK
CIK 1325879
Filed
Oct 20, 2022
Reporting period
Oct 16, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub